The U.S. Treasury Department has issued proposed regulations to implement the Comprehensive Outbound Investment National Security Act (COINS Act), which would expand the existing Outbound Investment Security Program to cover additional technology sectors, including biotechnology. Meanwhile, China's Ministry of Commerce (MOFCOM) and Ministry of Science and Technology have issued a notice soliciting public comments on proposed revisions to China's technology export control catalogue (Announcement No. 48). The proposed revisions cover 40 technologies across three sectors, including biopharmaceuticals, artificial intelligence and photovoltaics. These regulatory developments could have significant implications for cross-border investment, technology transfers, and licensing activities.

The American Chamber of Commerce in Shanghai's Healthcare Committee and Legal Committee will jointly host an online session on Tuesday, November 24, 2026, from 10:00 AM to 11:00 AM. John Tan, Partner at Arnold & Porter LLP will provide an overview of these regulatory developments and discuss their potential implications for U.S. healthcare and pharmaceutical companies operating in China.

Virtual Attendance: If you plan to join online, please select the "Join Virtually" ticket. A Zoom link will be sent to registered participants one day before the event.